FibroBiologics Inc. Commo... (FBLG)
NASDAQ: FBLG
· Real-Time Price · USD
0.62
0.05 (8.11%)
At close: Aug 18, 2025, 3:59 PM
0.62
0.89%
After-hours: Aug 18, 2025, 07:53 PM EDT
FibroBiologics Common Stock Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
Net Income | -13.22M | -7.67M | -11.16M | -17.78M | -19.47M | -22.53M | -16.48M | -8.29M | -7.66M | -5.5M | -3.09M | -1.56M | -2.04K | -1.02K |
Depreciation & Amortization | 663K | 597K | 573K | 550K | 519K | 478K | 437K | 536K | 424K | 325.06K | 229.12K | 118.00 | 118.00 | 59.00 |
Stock-Based Compensation | 2.4M | 2.24M | 2.22M | 2.11M | 1.97M | 1.84M | 1.76M | 1.36M | 993K | 545.08K | 97.17K | 65.17K | 168.00 | 84.00 |
Other Working Capital | -2.34M | -2.27M | -1.18M | 932K | 1.23M | 1.11M | 569K | 76K | -212K | -163.98K | -180.96K | -5.96K | 37.00 | 18.50 |
Other Non-Cash Items | -3.43M | -7.19M | -3.15M | 5.17M | 7.95M | 12.03M | 9M | 1.33M | 1.47M | 1.41M | 401.19K | 136.19K | 186.00 | 93.00 |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.88M | -1.42M | 559K | 1.16M | 1.7M | 1.17M | 493K | n/a | -510K | -438.98K | -180.96K | -5.96K | 37.00 | 18.50 |
Operating Cash Flow | -14.94M | -12.9M | -11.9M | -10.43M | -8.96M | -8.64M | -6.4M | -5.97M | -6.2M | -4.58M | -2.54M | -1.37M | -1.53K | -763 |
Capital Expenditures | -366K | -219K | -184K | -87K | -489K | -447K | -495K | -493K | -80K | -56K | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -366K | -219K | -184K | -87K | -489K | -447K | -495K | -493K | -80K | -56K | n/a | n/a | n/a | n/a |
Debt Repayment | 9.11M | 9.11M | 9.57M | 287K | 459K | 759K | 300K | 300K | n/a | -300K | -300K | -300K | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 4.38M | -172K | -172K | -172K | -172K | -2.01M | 7.66M | 7.66M | 7.66M | 9.68M | 4.08K | 4.08K | 4.08K | 2.04K |
Financial Cash Flow | 18.18M | 13.63M | 16.91M | 7.58M | 4.05M | 2.5M | 13.79M | 15.94M | 14.7M | 16.42M | 1.85M | -295.93K | 4.08K | 2.04K |
Net Cash Flow | 2.87M | 509K | 4.82M | -2.94M | -5.41M | -6.58M | 6.9M | 9.48M | 8.42M | 11.79M | -687.04K | -1.66M | 2.96K | n/a |
Free Cash Flow | -15.3M | -13.12M | -12.09M | -10.52M | -9.45M | -9.09M | -6.9M | -6.47M | -6.28M | -4.63M | -2.54M | -1.37M | -1.53K | -763 |